All Press Releases for July 27, 2017

Dongsoo Kim, PhD, Named a Lifetime Achiever by Marquis Who's Who

Dr. Kim has been endorsed by Marquis Who's Who as a leader in the biotechnology industry

Dr. Kim is the present research and development head of Welgene Research and Development Institute in Gyeongsan city, and a career biotechnology executive.

    GYEONGSAN, REPUBLIC OF KOREA, July 27, 2017 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to name Dongsoo Kim, PhD, a Lifetime Achiever. An accomplished listee, Dr. Kim celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he/ has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Kim is the present research and development head of Welgene Research and Development Institute in Gyeongsan city, and a career biotechnology executive. He holds dual doctorates in biology and life sciences, and leads Welgene in the fields of stemcell biotechnology, proteomics, immune cell biotechnology, and molecular anti-aging, promising fields on the frontier of medicine and bioengineering. Dr. Kim is the recipient of the 2014 75th IR52 Jang Young-Shil Award and the First Technology Innovation Award from the Korean Ministry of Science and Technology.

Born in Busan in 1965, Dr. Kim studied with the National Fisheries University of Busan before earning a Master's degree from the graduate school of Busan National University. He went on to earn a PhD with their department of biology before working on a second doctorate with the University of Liverpool Medical School in the HACB department of the school of life sciences. Dr. Kim initially worked with Goam Genetics Institute with Kittolife in Busan, and in 2009, he went on to become research and development head with Prostemics Instiute in Seongnam, Republic of Korea.

In 2011, he accepted a position with Ozlibio in the capital of Seoul, and in 2013, Dr. Kim joined Stemmedicine/Stemmedicare as chief research and development advisor. He served for one year as managing director and laboratory head of the advanced cell lab in Aribio Company before accepting his current position with Welgene.

Dr. Kim holds a number of patents in the field of stem cell research, including adult mesenchymal stem cells for anti-aging, implantable co-polymers for tissue engineering, anti-inflammatory ginsenosides from Korea Hongsam, cartilage regeneration scaffolding, and adipose-derived stemcells for cosmetic applications. He is a member of the Korean Tissue Engineering and Regenerative Medicine Society and the Korean Society of Molecular and Cellular Biology. For his advances in a vital field of biotechnology, Dr. Kim was selected for inclusion in the 2016 volume of Who's Who in the World. He enjoys hiking, and is a skateboard enthusiast.

In recognition of outstanding contributions to his profession and the Marquis Who's Who community, Dr. Kim has been featured on the Marquis Who's Who Lifetime Achievers website. Please visit for more information about this honor.

About Marquis Who's Who :
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America , Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis publications may be visited at the official Marquis Who's Who website at

# # #

Contact Information

Fred Marks
Marquis Who's Who Ventures LLC
Berkeley Heights, NJ
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: